Kazia Therapeutics Limite...

NASDAQ: KZIA · Real-Time Price · USD
9.42
0.37 (4.09%)
At close: Jun 17, 2025, 10:07 AM

Kazia Therapeutics Revenue Breakdown

Period Ending Jun 30, 2024 Jun 30, 2021
Licensing Revenue Revenue 2.3M 15.18M
Licensing Revenue Revenue Growth -84.84% n/a

Revenue by Geography

Period Ending Jun 30, 2021
China Revenue 10.01M
China Revenue Growth n/a
Swedan Revenue 5.18M
Swedan Revenue Growth n/a

Operating Expense Breakdown

Period Ending Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021 Dec 31, 2020 Jun 30, 2020 Dec 31, 2019 Jun 30, 2019 Dec 31, 2018 Jun 30, 2018 Dec 31, 2017 Jun 30, 2017 Dec 31, 2016 Jun 30, 2016 Dec 31, 2015 Jun 30, 2015
Selling, General, and Administrative Revenue 9.01M 4.56M 4.31M 4.28M 2.76M 2.48M 3.45M 3.58M 1.59M 2.1M 1.7M 2.09M 1.14M 4.46M 4.56M 3.97M 2.68M 3.08M 2.33M
Selling, General, and Administrative Revenue Growth +97.72% +5.79% +0.70% +55.06% +11.09% -27.96% -3.62% +125.55% -24.68% +23.87% -18.55% +82.70% -74.38% -2.25% +14.86% +48.14% -13.02% +32.19% n/a
Research and Development Revenue 13.05M 4.33M 6.2M 9.36M 9.18M 10.99M 11.68M 2.86M 5.3M 4.2M 2.77M 3.71M 5.08M 4.7M 6.26M 4.88M 4.88M 5.01M 3.34M
Research and Development Revenue Growth +201.60% -30.24% -33.72% +1.95% -16.45% -5.94% +308.52% -46.04% +26.30% +51.62% -25.38% -26.97% +8.11% -24.92% +28.16% -0.05% -2.55% +49.96% n/a